(Q61975776)
Statements
An Open,Multi Center Trial to Evaluate the Efficacy and Safety of High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced Non-Small Cell Lung Cancer Patients After Failure of Standard Dose EGFR-TKIs (English)
0 references
October 2013
0 references
December 2017
0 references
20
0 references
18 year
0 references
75 year
0 references